← Back to Clinical Trials
Recruiting NCT07124572
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
Trial Parameters
Condition Thyroid Associated Ophthalmopathy
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 7 Years
Max Age 90 Years
Start Date 2022-10-01
Completion 2030-10-01
Interventions
Imaging and ocular examinations
Brief Summary
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
Eligibility Criteria
Inclusion Criteria: * normal participants without eyelid disorders (control group) * patients with thyroid-associated ophthalmopathy (TAO group) * cooperative participants Exclusion Criteria: * participants with pupil or cornea disorders * participants with history of eye injury
Related Trials
NCT04662190
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
View Trial →
NCT04936854
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
View Trial →
NCT07124572
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophtha
View Trial →